696 related articles for article (PubMed ID: 32297435)
1. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry.
Husson O; de Rooij BH; Kieffer J; Oerlemans S; Mols F; Aaronson NK; van der Graaf WTA; van de Poll-Franse LV
Oncologist; 2020 Apr; 25(4):e722-e732. PubMed ID: 32297435
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
[TBL] [Abstract][Full Text] [Related]
3. Baseline functioning scales of EORTC QLQ-C30 predict overall survival in patients with gastrointestinal cancer: a meta-analysis.
Zang Y; Qiu Y; Sun Y; Fan Y
Qual Life Res; 2024 Jun; 33(6):1455-1468. PubMed ID: 38227073
[TBL] [Abstract][Full Text] [Related]
4. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.
Quinten C; Coens C; Mauer M; Comte S; Sprangers MA; Cleeland C; Osoba D; Bjordal K; Bottomley A;
Lancet Oncol; 2009 Sep; 10(9):865-71. PubMed ID: 19695956
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
6. Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients.
Grande GE; Farquhar MC; Barclay SI; Todd CJ
Palliat Support Care; 2009 Sep; 7(3):289-97. PubMed ID: 19788770
[TBL] [Abstract][Full Text] [Related]
7. The association of liver function and quality of life of patients with liver cancer.
Li L; Mo F; Hui EP; Chan SL; Koh J; Tang NLS; Yu SCH; Yeo W
BMC Gastroenterol; 2019 May; 19(1):66. PubMed ID: 31046687
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study.
van Kleef JJ; Dijksterhuis WPM; van den Boorn HG; Prins M; Verhoeven RHA; Gisbertz SS; Slingerland M; Mohammad NH; Creemers GJ; Neelis KJ; Heisterkamp J; Rosman C; Ruurda JP; Kouwenhoven EA; van de Poll-Franse LV; van Oijen MGH; Sprangers MAG; van Laarhoven HWM;
Gastric Cancer; 2021 Nov; 24(6):1203-1212. PubMed ID: 34251543
[TBL] [Abstract][Full Text] [Related]
9. Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials.
Ediebah DE; Quinten C; Coens C; Ringash J; Dancey J; Zikos E; Gotay C; Brundage M; Tu D; Flechtner HH; Greimel E; Reeve BB; Taphoorn M; Reijneveld J; Dirven L; Bottomley A;
Cancer; 2018 Aug; 124(16):3409-3416. PubMed ID: 29905936
[TBL] [Abstract][Full Text] [Related]
10. Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies.
Efficace F; Cottone F; Sommer K; Kieffer J; Aaronson N; Fayers P; Groenvold M; Caocci G; Lo Coco F; Gaidano G; Niscola P; Baccarani M; Rosti G; Venditti A; Angelucci E; Fazi P; Vignetti M; Giesinger J
Value Health; 2019 Nov; 22(11):1303-1310. PubMed ID: 31708068
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients.
Mol L; Ottevanger PB; Koopman M; Punt CJ
Eur J Cancer; 2016 Oct; 66():138-43. PubMed ID: 27573427
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaire.
Anker MS; Potthoff SK; Lena A; Porthun J; Hadzibegovic S; Evertz R; Denecke C; Fröhlich AK; Sonntag F; Regitz-Zagrosek V; Rosen SD; Lyon AR; Lüscher TF; Spertus JA; Anker SD; Karakas M; Bullinger L; Keller U; Landmesser U; Butler J; von Haehling S
Eur J Heart Fail; 2023 Sep; 25(9):1635-1647. PubMed ID: 37369985
[TBL] [Abstract][Full Text] [Related]
13. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients.
Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AK; Tang NL; Chu CM; Hui J; Lee KF; Yu S; Yeo W
Qual Life Res; 2019 Sep; 28(9):2597-2607. PubMed ID: 31037590
[TBL] [Abstract][Full Text] [Related]
14. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
Movsas B; Moughan J; Sarna L; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Wasserman T; Bruner DW
J Clin Oncol; 2009 Dec; 27(34):5816-22. PubMed ID: 19858383
[TBL] [Abstract][Full Text] [Related]
15. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.
Pilz MJ; Gamper EM; Efficace F; Arraras JI; Nolte S; Liegl G; Rose M; Giesinger JM;
BMC Public Health; 2022 May; 22(1):1040. PubMed ID: 35610611
[TBL] [Abstract][Full Text] [Related]
16. Differences in Quality of Life between German and Dutch Patients with Prostate Cancer Treated with Robot-assisted Radical Prostatectomy: Implications for International Multicenter Randomized Controlled Trials.
Wagner C; Witt JH; Nolte S; van der Poel HG; Aaronson NK; Kolvatzis M; Tian Z; Mendrek M; Liakos N; Gratzke C; Leyh-Bannurah SR
Eur Urol Focus; 2023 Feb; ():. PubMed ID: 36863963
[TBL] [Abstract][Full Text] [Related]
17. Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust.
Giesinger JM; Kieffer JM; Fayers PM; Groenvold M; Petersen MA; Scott NW; Sprangers MA; Velikova G; Aaronson NK;
J Clin Epidemiol; 2016 Jan; 69():79-88. PubMed ID: 26327487
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between Quality of Life and Survival in Patients With Pancreatic and Periampullary Cancer: A Multicenter Cohort Analysis.
Mackay TM; Latenstein AEJ; Sprangers MAG; van der Geest LG; Creemers GJ; van Dieren S; de Groot JB; Groot Koerkamp B; de Hingh IH; Homs MYV; de Jong EJM; Molenaar IQ; Patijn GA; van de Poll-Franse LV; van Santvoort HC; de Vos-Geelen J; Wilmink JW; van Eijck CH; Besselink MG; van Laarhoven HWM;
J Natl Compr Canc Netw; 2020 Oct; 18(10):1354-1363. PubMed ID: 33022643
[TBL] [Abstract][Full Text] [Related]
19. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV;
Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189
[TBL] [Abstract][Full Text] [Related]
20. Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses.
Lenz HJ; Argiles G; Yoshino T; Lonardi S; Falcone A; Limón ML; Sobrero A; Hastedt C; Peil B; Voss F; Griebsch I; Van Cutsem E
Clin Colorectal Cancer; 2019 Dec; 18(4):269-279.e5. PubMed ID: 31628043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
